*Applications will be reviewed on a rolling- basis. Early submission of applications is strongly encouraged. A selection may be made at any time during the review process.
Two fellowship opportunities are available at the U.S. Food and Drug Administration (FDA), Public Health Strategy and Analysis Staff (PHSA) in the Office of the Commissioner located in Silver Spring, Maryland. However, this opportunity will begin remotely while pandemic related restrictions are in place. After restrictions are lifted, the participation will be expected to complete the appointment in-person from the FDA campus.
Potential health policy and research training projects related to FDA's domestic and/or global regulatory efforts for PHSA ORISE fellows, under the guidance of a mentor, include (but are not limited to) research and analysis of: 1.Generic drug development and competition, with ongoing and new research that seeks to determine the impact of generic drugs on competition and pricing 2.The opioid epidemic, with projects aimed at improving our understanding of the impact of laws and policies surrounding opioids 3.Quality of drug marketing applications submitted to the FDA, with ongoing and new initiatives that evaluate the application process and quality of the applications reviewed by the FDA; and 4.Other priority issues as they come up, including on emergent issues, such as projects related to COVID-19 or health equity.
If you have questions about the nature of the fellowship, please reach out to the coordinator at OPHSAFellows@fda.hhs.gov.
Anticipated Appointment Start Date (start date is flexible): •A part-time or full-time fellow between January 1, 2022 to September 30, 2022 •A full-time fellow starting September 1, 2022
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. The annual stipend range is ~$60,000 per year to ~$72,000 per year. A health insurance supplement will also be provided. Limited moving or other travel- related expenses may be reimbursed. Proof of health insurance is required for participation in this program. Health insurance can be obtained through ORISE. The appointment is full-time or part-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.